PALIRIS XR

Description

Composition: Paliperidone (Extended Release)

Product Type: Extended-Release Tablet

Quantity: 30 tablets

Strength/Dosage: 1.5 mg, 3 mg, or 6 mg per tablet

Indications:

Treatment of schizophrenia in adults and adolescents.
Management of schizoaffective disorder as monotherapy or in combination with mood stabilizers or antidepressants.
Improvement of symptoms such as hallucinations, delusions, and thought disturbances.
Prevention of relapse in patients with schizophrenia.
Treatment of acute psychotic episodes associated with schizophrenia.